Bio-Rad Laboratories, Inc. (BIO) financial statements (2020 and earlier)

Company profile

Business Address 1000 ALFRED NOBEL DRIVE
HERCULES, CA 94547
State of Incorp. DE
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments979845755839786698609
Cash and cash equivalents561432384456458413332
Short-term investments418413371383329284277
Restricted cash and investments66654  
Receivables356392465372391378423
Inventory, net of allowances, customer advances and progress billings588584595525490471501
Inventory588584595525490471501
Prepaid expense1101871469194108136
Other current assets9101012116279
Total current assets:2,0482,0231,9771,8451,7781,7161,748
Noncurrent Assets
Operating lease, right-of-use asset218
Property, plant and equipment496509493489438429429
Long-term investments and receivables3,9322,6561,028831720389378
Long-term investments3,9322,6561,028831720389378
Intangible assets, net (including goodwill)411353680639710755784
Goodwill264220506477496500518
Intangible assets, net (excluding goodwill)147133174162214254266
Restricted cash and investments2      
Other noncurrent assets 7095    
Other undisclosed noncurrent assets71  48665250
Total noncurrent assets:5,1293,5882,2962,0061,9341,6251,641
TOTAL ASSETS:7,1775,6114,2733,8513,7123,3413,389
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities250295347325310317313
Accounts payable 122135133122129149
Employee-related liabilities 144172163158153131
Taxes payable35294028293534
Other undisclosed accounts payable and accrued liabilities215      
Debt38000000
Deferred revenue and credits2831302726
Other liabilities11310112711510210397
Other undisclosed current liabilities3354    51
Total current liabilities:434451503471441447487
Noncurrent Liabilities
Long-term debt and lease obligation, including:642439435434436436436
Long-term debt, excluding current maturities438     436
Finance lease, liability11
Operating lease, liability193
Other undisclosed long-term debt and lease obligation 439435434436436 
Liabilities, other than long-term debt143701405358344274279
Deferred tax liabilities, net553222223233155162
Other liabilities143148183135111119117
Other undisclosed noncurrent liabilities827      
Total noncurrent liabilities:1,6121,140840792780709715
Total liabilities:2,0461,5911,3431,2641,2211,1561,202
Stockholders' equity
Stockholders' equity attributable to parent, including:5,1314,0202,9302,5872,4912,1852,187
Additional paid in capital396394361333300271240
Accumulated other comprehensive income (loss)(152)(47)739418382219341
Retained earnings4,9173,7221,8301,8361,8081,6951,606
Other undisclosed stockholders' equity attributable to parent(30)(49)(0)(0)(0)(0)(0)
Total stockholders' equity:5,1314,0202,9302,5872,4912,1852,187
TOTAL LIABILITIES AND EQUITY:7,1775,6114,2733,8513,7123,3413,389

Income statement (P&L) ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Revenues2,3042,2892,1602,0682,0192,1752,133
Revenue, net2,1602,0682,0192,1752,133
Cost of revenue
(Cost of Goods and Services Sold)
(1,045)(1,066)(973)(930)(898)(997)(954)
Other undisclosed gross profit00   0 
Gross profit:1,2591,2231,1871,1381,1221,1791,178
Operating expenses(1,316)(1,326)(1,071)(1,085)(955)(1,103)(1,055)
Other undisclosed operating income     7546
Operating income (loss):(57)(103)11753167150169
Nonoperating income313431011717
Investment income, nonoperating27    1313
Foreign currency transaction loss, before tax (3)(9)(5)(10)(9)(9)
Other nonoperating income1371215111313
Interest and debt expense(23)(24)(22)(22)(22)(22)(77)
Other undisclosed income (loss) from continuing operations before equity method investments, income taxes569606   (13)3
Income from continuing operations before income taxes:5205139842146132112
Income tax expense (benefit)(144)(147)24(13)(33)(43)(35)
Net income:377366122281138978
Net loss attributable to noncontrolling interest      (0)
Net income available to common stockholders, diluted:377366122281138978

Comprehensive Income ($ in millions)

9/30/2019
TTM
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
12/31/2013
Net income:377366122281138978
Other comprehensive income (loss)(120)(106)32136163(122)66
Comprehensive income (loss):25725944364276(33)144
Comprehensive income, net of tax, attributable to noncontrolling interest      0
Other undisclosed comprehensive loss, net of tax, attributable to parent      (0)
Comprehensive income (loss), net of tax, attributable to parent:25725944364276(33)144

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: